162
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Molecular docking-based classification and systematic QSAR analysis of indoles as Pim kinase inhibitors

& ORCID Icon
Pages 399-419 | Received 12 Feb 2020, Accepted 31 Mar 2020, Published online: 22 Apr 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

H. Rezaie, M. Asadollahi-Baboli & S.K. Hassaninejad-Darzi. (2022) Hybrid consensus and k-nearest neighbours (kNN) strategies to classify dual BRD4/PLK1 inhibitors. SAR and QSAR in Environmental Research 33:10, pages 779-792.
Read now
M. Haroun, A. Petrou, C. Tratrat, K. Kositsi, A. Gavalas, A. Geronikaki, K.N. Venugopala & N. Sreeharsha. (2022) Discovery of benzothiazole-based thiazolidinones as potential anti-inflammatory agents: anti-inflammatory activity, soybean lipoxygenase inhibition effect and molecular docking studies. SAR and QSAR in Environmental Research 33:6, pages 485-497.
Read now
M. Merlani, V. Barbakadze, L. Amiranashvili, L. Gogilashvili, A. Petrou, A. Geronikaki, A. Ćirić, J. Glamočlija & M. Soković. (2022) Caffeic and 3-(3,4-dihydroxyphenyl)glyceric acid derivatives as antimicrobial agent: biological evaluation and molecular docking studies. SAR and QSAR in Environmental Research 33:4, pages 307-321.
Read now
M. Gholamhoseinnia & M. Asadollahi-Baboli. (2022) Ranked binding energies of residues and data fusion to identify the active and selective pyrimidine-based Janus kinases 3 (JAK3) inhibitors. SAR and QSAR in Environmental Research 33:1, pages 23-34.
Read now

Articles from other publishers (1)

Marina Gorostiola González, Antonius P.A. Janssen, Adriaan P. IJzerman, Laura H. Heitman & Gerard J.P. van Westen. (2022) Oncological drug discovery: AI meets structure-based computational research. Drug Discovery Today 27:6, pages 1661-1670.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.